Monday, 18 January 2021

DKMS funds research scholarships to young scientists

07 October 2020 | News

It is active in India- in cooperation with its partner organization DKMS BMST Foundation India

Image credit: DKMS

Image credit: DKMS

Germany based DKMS Stiftung Leben Spenden (Foundation for Giving Life) that supports up to four international young scientists each year who want to advance the fight against blood cancer with their promising research projects, is inviting young scientists to apply for John Hansen Research Grant.

Each winner will receive $270,000 (€240,000) over a period of three years. Up to four scientists with promising research projects in the field of stem cell transplantation and cell therapy dedicated to the fight against blood cancer and life-threatening blood disorders will be funded. One of the prerequisites for participation is a doctorate or comparable qualification, which dates back twelve years at maximum.

DKMS is well-known as an international nonprofit organization in the fight against blood cancer. Until today DKMS has provided more than 87,000 patients across the globe a chance at life by facilitating blood stem cell transplants. In addition, the world's leading stem cell donor center is highly committed in the medical-scientific field in order to continually improve the survival and healing chances of blood cancer patients. This includes the HLA high-performance laboratory in Dresden and its own research unit, the Clinical Trials Unit. The Clinical Trials Unit systematically searches for additional immunogenetic factors that could positively influence the success of a stem cell transplantation.

DKMS is an international nonprofit organization dedicated to the fight against blood cancer. Its goal is to give as many patients with blood cancer as possible a second chance at life. The organization is a world leader in providing patients with life-saving stem cell transplants. In addition, it is active in India - in cooperation with its partner organization DKMS BMST Foundation India.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls